{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:52:23Z","timestamp":1773028343039,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 0315742"],"award-info":[{"award-number":["FKZ 0315742"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.tox.2016.09.018","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T20:04:28Z","timestamp":1475352268000},"page":"94-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Inhibition of \u03b2-catenin signaling by phenobarbital in hepatoma cells in vitro"],"prefix":"10.1016","volume":"370","author":[{"given":"Nicola","family":"Groll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Petrikat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joern","family":"Dengjel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Gretzmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Poetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas O.","family":"Joos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Braeuning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2016.09.018_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuron.2007.01.016","article-title":"NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression","volume":"53","author":"Abe","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tox.2016.09.018_bib0010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.18433\/J3CG6G","article-title":"Paradoxical signaling pathways in developing thymocytes","volume":"14","author":"Alshamsan","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.tox.2016.09.018_bib0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.gene.2007.12.009","article-title":"NRF-1, and AP-1 regulate the promoter of the human calpain small subunit 1 (CAPNS1) gene","volume":"410","author":"Asangani","year":"2008","journal-title":"Gene"},{"key":"10.1016\/j.tox.2016.09.018_bib0020","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1038\/sj.onc.1204982","article-title":"Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors","volume":"20","author":"Aydinlik","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2016.09.018_bib0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BSE0450095","article-title":"Systems analysis of MAPK signal transduction","volume":"45","author":"Bluthgen","year":"2008","journal-title":"Essays Biochem."},{"key":"10.1016\/j.tox.2016.09.018_bib0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.15252\/msb.20156642","article-title":"Signaling output: it's all about timing and feedbacks","volume":"11","author":"Bluthgen","year":"2015","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.tox.2016.09.018_bib0035","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00204-016-1712-0","article-title":"Is the question of phenobarbital as potential liver cancer risk factor for humans really resolved?","volume":"90","author":"Braeuning","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2016.09.018_bib0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/BSR20120043","article-title":"The nuclear factor kappaB inhibitor (E)-2-fluoro-4'-methoxystilbene inhibits firefly luciferase","volume":"32","author":"Braeuning","year":"2012","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.tox.2016.09.018_bib0045","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1111\/j.1742-4658.2007.06002.x","article-title":"Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes","volume":"274","author":"Braeuning","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.tox.2016.09.018_bib0050","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1124\/dmd.108.026179","article-title":"Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1","volume":"37","author":"Braeuning","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2016.09.018_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/toxsci\/kfr080","article-title":"Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway","volume":"122","author":"Braeuning","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.09.018_bib0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/toxsci\/kfu099","article-title":"Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR","volume":"140","author":"Braeuning","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.09.018_bib0065","first-page":"299","article-title":"Model systems for understanding mechanisms of nongenotoxic carcinogenesis: response","volume":"147","author":"Braeuning","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.09.018_bib0070","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00204-016-1667-1","article-title":"Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice","volume":"90","author":"Braeuning","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2016.09.018_bib0075","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00204-014-1331-6","article-title":"Liver cell proliferation and tumor promotion by phenobarbital: relevance for humans?","volume":"88","author":"Braeuning","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2016.09.018_bib0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2016.09.018_bib0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tox.2013.03.019","article-title":"The time point of beta-catenin knockout in hepatocytes determines their response to xenobiotic activation of the constitutive androstane receptor","volume":"308","author":"Ganzenberg","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2016.09.018_bib0090","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1096\/fj.09-136325","article-title":"De novo synthesis of {beta}-catenin via H-Ras and MEK regulates airway smooth muscle growth","volume":"24","author":"Gosens","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.tox.2016.09.018_bib0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jprot.2015.04.017","article-title":"Towards multiplexed protein-protein interaction analysis using protein tag-specific nanobodies","volume":"127","author":"Groll","year":"2015","journal-title":"J. Proteomics"},{"key":"10.1016\/j.tox.2016.09.018_bib0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/978-1-4939-2550-6_31","article-title":"A bead-based multiplex sandwich immunoassay to assess the abundance and posttranslational modification state of beta-catenin","volume":"1295","author":"Groll","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tox.2016.09.018_bib0105","first-page":"350","article-title":"Coordinate regulation of Cyp2e1 by beta-catenin- and hepatocyte nuclear factor 1alpha-dependent signaling","author":"Groll","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2016.09.018_bib0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/hsz-2015-0223","article-title":"Phenobarbital inhibits calpain activity and expression in mouse hepatoma cells","volume":"397","author":"Groll","year":"2016","journal-title":"Biol. Chem."},{"key":"10.1016\/j.tox.2016.09.018_bib0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00613432","article-title":"Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients","volume":"9","author":"Houghton","year":"1975","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2016.09.018_bib0120","series-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 79","first-page":"161","article-title":"Phenobarbital and its sodium salt","author":"IARC","year":"2001"},{"key":"10.1016\/j.tox.2016.09.018_bib0125","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/sj.onc.1208265","article-title":"B-raf and Ha-ras mutations in chemically induced mouse liver tumors","volume":"24","author":"Jaworski","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2016.09.018_bib0130","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/ijc.22801","article-title":"Global gene expression in Ha-ras and B-raf mutated mouse liver tumors","volume":"121","author":"Jaworski","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tox.2016.09.018_bib0135","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1128\/MCB.25.12.5031-5039.2005","article-title":"Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translation","volume":"25","author":"Karni","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tox.2016.09.018_bib0140","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.febslet.2005.02.002","article-title":"When kinases meet mathematics: the systems biology of MAPK signalling","volume":"579","author":"Kolch","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tox.2016.09.018_bib0145","doi-asserted-by":"crossref","first-page":"e53050","DOI":"10.1371\/journal.pone.0053050","article-title":"Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation","volume":"7","author":"Kollmorgen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2016.09.018_bib0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mc.2940060210","article-title":"p53 mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors","volume":"6","author":"Kress","year":"1992","journal-title":"Mol. Carcinogenesis"},{"key":"10.1016\/j.tox.2016.09.018_bib0155","article-title":"Comparative analysis of 3D culture methods on human HepG2 cells","author":"Luckert","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2016.09.018_bib0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00432-003-0431-0","article-title":"The Wnt signaling pathway and its role in tumor development","volume":"129","author":"Lustig","year":"2003","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tox.2016.09.018_bib0165","first-page":"713","article-title":"Anticonvulsant drugs: mechanisms of action","volume":"44","author":"Macdonald","year":"1986","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.tox.2016.09.018_bib0170","first-page":"5087","article-title":"Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice","volume":"60","author":"Moennikes","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2016.09.018_bib0175","doi-asserted-by":"crossref","first-page":"ra31","DOI":"10.1126\/scisignal.2003705","article-title":"Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling","volume":"6","author":"Mutoh","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tox.2016.09.018_bib0180","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tox.2016.09.018_bib0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1389200054633899","article-title":"CAR, the continuously advancing receptor, in drug metabolism and disease","volume":"6","author":"Qatanani","year":"2005","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.tox.2016.09.018_bib0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/toxsci\/kft034","article-title":"Biological and tumor-promoting effects of dioxin-like and non-dioxin-like polychlorinated biphenyls in mouse liver after single or combined treatment","volume":"133","author":"Rignall","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.09.018_bib0195","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1093\/nar\/gkv423","article-title":"Signal integration by the CYP1A1 promoter\u2014a quantitative study","volume":"43","author":"Schulthess","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tox.2016.09.018_bib0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/pmic.200800275","article-title":"Global analysis of cellular protein translation by pulsed SILAC","volume":"9","author":"Schwanhausser","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.tox.2016.09.018_bib0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","article-title":"EGF receptor trafficking: consequences for signaling and cancer","volume":"24","author":"Tomas","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tox.2016.09.018_bib0210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1074\/mcp.M114.044016","article-title":"Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells","volume":"14","author":"Traenkle","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.tox.2016.09.018_bib0215","doi-asserted-by":"crossref","first-page":"8759","DOI":"10.1038\/srep08759","article-title":"Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry","volume":"5","author":"Weiss","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2016.09.018_bib0220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0163-7258(96)00067-8","article-title":"Phenobarbital mechanistic data and risk assessment: enzyme induction enhanced cell proliferation, and tumor promotion","volume":"71","author":"Whysner","year":"1996","journal-title":"Pharmacol. Therap."},{"key":"10.1016\/j.tox.2016.09.018_bib0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/toxsci\/kfu173","article-title":"Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver","volume":"142","author":"Yamada","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.09.018_bib0230","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1158\/0008-5472.CAN-04-1459","article-title":"The orphan nuclear receptor constitutive active\/androstane receptor is essential for liver tumor promotion by phenobarbital in mice","volume":"64","author":"Yamamoto","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2016.09.018_bib0235","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1515\/hsz-2012-0130","article-title":"Dual-specificity phosphatases are targets of the Wnt\/beta-catenin pathway and candidate mediators of beta-catenin\/Ras signaling interactions","volume":"393","author":"Zeller","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.tox.2016.09.018_bib0240","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00204-013-1035-3","article-title":"Mechanisms of RAS\/beta-catenin interactions","volume":"87","author":"Zeller","year":"2013","journal-title":"Arch. Toxicol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16302335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16302335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:34:08Z","timestamp":1759534448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X16302335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":48,"alternative-id":["S0300483X16302335"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2016.09.018","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of \u03b2-catenin signaling by phenobarbital in hepatoma cells in vitro","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2016.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}